Benzinga | Nov 9, 2021 11:45AM EST

Eloxx Pharmaceuticals Q3 EPS $(0.11) Up From $(0.16) YoY

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.11) per share. This is a 31.25 percent increase over losses of $(0.16) per share from the same period last year.